Arecoline suppresses HaCaT cell proliferation through cell cycle regulatory molecules

Oncology Reports

Volumn 29, Issue 6, 2013, Pages 2438-2444

  Zhou, Zhong Su ^a   Li, Ming ^a,b   Gao, Feng ^c   Peng, Jie Ying ^b   Xiao, Hai Bo ^a   Dai, Li Xia ^a   Lin, Shi Rong ^d   Zhang, Rui ^a   Jin, Long Yu ^c  

^a Changsha Stomatology Hospital   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d NONE   (Taiwan)

Author keywords

Carcinogenesis; Cell cycle; Oral submucous fibrosis; Proliferation

Indexed keywords

ARECOLINE; BETA ACTIN; CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; TRANSCRIPTION FACTOR E2F1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; UPREGULATION; WESTERN BLOTTING;

ARECOLINE; CARCINOGENS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; DNA DAMAGE; GENE EXPRESSION REGULATION; HUMANS;

EID: 84876243714     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2360     Document Type: Article

References (29)

1. Chaturvedi P, Vaishampayan SS, Nair S, et al: Oral squamous cell carcinoma arising in background of oral submucous fibrosis: A clinicopathologically distinct disease. Head Neck: Sep 13, 2012 (Epub ahead of print). doi: 10.1002/hed.23143.
2. Mehrotra D, Kumar S, Agarwal GG, Asthana A and Kumar S: Odds ratio of risk factors for oral submucous fibrosis in a case control model. Br J Oral Maxillofac Surg: Aug 27, 2012 (Epub ahead of print).
3. Khan S, Chatra L, Prashanth SK, Veena KM and Rao PK: Pathogenesis of oral submucous fibrosis. J Cancer Res Ther 8: 199-203, 2012.
4. Kothari MC, Hallur N, Sikkerimath B, Gudi S and Kothari CR: Coronoidectomy, masticatory myotomy and buccal fat pad graft in management of advanced oral submucous fibrosis. Int J Oral Maxillofac Surg 41: 1416-1421, 2012.
5. Ranganathan K and Kavitha R: Proliferation and apoptosis markers in oral submucous fibrosis. J Oral Maxillofac Pathol 15: 148-153, 2011.
6. Khan I, Agarwal P, Thangjam GS, Radhesh R, Rao SG and Kondaiah P: Role of TGF-β and BMP7 in the pathogenesis of oral submucous fibrosis. Growth Factors 29: 119-127, 2011.
7. Tadakamadla J, Kumar S and Mamatha GP: Evaluation of serum copper and iron levels among oral submucous fibrosis patients. Med Oral Patol Oral Cir Bucal 16: e870-e873, 2011
8. Wang YC, Tsai YS, Huang JL, et al: Arecoline arrests cells at prometaphase by deregulating mitotic spindle assembly and spindle assembly checkpoint: implication for carcinogenesis. Oral Oncol 46: 255-262, 2010.
9. Lee PH, Chang MC, Chang WH, et al: Prolonged exposure to arecoline arrested human KB epithelial cell growth: regulatory mechanisms of cell cycle and apoptosis. Toxicology 220: 81-89, 2006.
10. 1 phase arrests and senescence-associated phenotypes in normal human oral keratinocyte. Carcinogenesis 27: 1273-1284, 2006.
11. Tu HF, Liu CJ, Chang CS, Lui MT, Kao SY, Chang CP and Liu TY: The functional (-1171 5A→6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users. J Oral Pathol Med 35: 99-103, 2006
12. Chiu CJ, Chiang CP, Chang ML, et al: Association between genetic polymorphism of tumor necrosis factor-alpha and risk of oral submucous fibrosis, a pre-cancerous condition of oral cancer. J Dent Res 80: 2055-2059, 2001.
13. Huang LW, Hsieh BS, Cheng HL, Hu YC, Chang WT and Chang KL: Arecoline decreases interleukin-6 production and induces apoptosis and cell cycle arrest in human basal cell carcinoma cells. Toxicol Appl Pharmacol 258: 199-207, 2012.
14. Tsai YS, Lee KW, Huang JL, et al: Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells. Toxicology 249: 230-237, 2008.
15. Mishra R and Das BR: Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression. Arch Oral Biol 54: 917-923, 2009.
16. Liu L, Xie H, Chen X, Shi W, Xiao X, Lei D and Li J: Differential response of normal human epidermal keratinocytes and HaCaT cells to hydrogen peroxide-induced oxidative stress. Clin Exp Dermatol 37: 772-780, 2012.
17. Zhou Y, Zeng Z, Zhang W, et al: Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer 123: 2065-2072, 2008.
18. Zhou Y, Zeng Z, Zhang W, et al: Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization. Eur J Cancer Prev 17: 561-571, 2008.
19. Kuo FC, Wu DC, Yuan SS, et al: Effects of arecoline in relaxing human umbilical vessels and inhibiting endothelial cell growth. J Perinat Med 33: 399-405, 2005.
20. Bartek J, Lukas J and Bartkova J: Perspective: defects in cell cycle control and cancer. J Pathol 187: 95-99, 1999. (Pubitemid 29009839)
21. Malumbres M: Cyclins and related kinases in cancer cells. J BUON 12 (Suppl 1): S45-S52, 2007.
22. van den Heuvel S: Cell-cycle regulation. WormBook 1-16, 2005.
23. Chen HZ, Tsai SY and Leone G: Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 9: 785-797, 2009.
24. Kwong RA, Nguyen TV, Bova RJ, et al: Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue. Clin Cancer Res 9: 3705-3711, 2003. (Pubitemid 37169239)
25. Luo X, Pan Q, Liu L, et al: Genomic and proteomic profiling II: comparative assessment of gene expression profiles in leiomyomas, keloids and surgically-induced scars. Reprod Biol Endocrinol 5: 35, 2007.
26. 2 DNA damage checkpoint. DNA Repair 7: 136-140, 2008.
27. Miyazaki T and Arai S: Two distinct controls of mitotic cdk1/cyclin B1 activity requisite for cell growth prior to cell division. Cell Cycle 6: 1419-1425, 2007.
28. Yu Y, Kovacevic Z and Richardson DR: Tuning cell cycle regulation with an iron key. Cell Cycle 6: 1982-1994, 2007. (Pubitemid 47327885)
29. Nakayama KI and Nakayama K: Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 6: 369-381, 2006.